LCPUFA Supplementation: A Multi-Modality Imaging Study
NCT02076048 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 42
Last updated 2015-10-08
Summary
The purpose of this study is to take images of the brain in order to see if long-chain polyunsaturated fatty acid (LCPUFA) exposure during infancy influences brain structure and function in middle childhood.
Conditions
- Child Development
Sponsors & Collaborators
-
Mead Johnson Nutrition
collaborator INDUSTRY -
Kathleen Gustafson, Ph.D.
lead OTHER
Principal Investigators
-
Kathleen M Gustafson, PhD · University of Kansas Medical Center
Eligibility
- Min Age
- 7 Years
- Max Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-07-31
- Primary Completion
- 2015-08-31
- Completion
- 2015-09-30
Countries
- United States
Study Locations
More Related Trials
-
Polyunsaturated Fatty Acids in Child Nutrition
NCT01487889 ·Status: COMPLETED ·Phase: NA
-
Polyunsaturated Fatty Acids (PUFA) Status and Cognitive Function in Healthy Young Adults
NCT01075958 ·Status: COMPLETED
-
Essential Fatty Acid (EFA) Nutrition 5-Year-Olds X Section
NCT01112930 ·Status: COMPLETED
-
Investigating the Effects of Nutrition on the Maturation of Brain Networks Associated With Memory in Infants
NCT02457078 ·Status: UNKNOWN ·Phase: NA
-
Essential Fatty Acid (EFA) Nutrition 5-Year-Olds Follow-Up Study
NCT01112904 ·Status: COMPLETED
-
DHA & Lutein and fMRI Brain Mapping in Healthy Children
NCT01789866 ·Status: COMPLETED
-
Effects of Omega-3 Fatty Acids Supplementation on Brain and Behaviour in Healthy Children.
NCT02346773 ·Status: COMPLETED ·Phase: NA
-
Assessment of Fatty Acids in Infants' Blood Cells When Consuming Infant Formula Containing Long-Chain Polyunsaturated Fatty Acids
NCT01058187 ·Status: COMPLETED
-
Walnuts, Long-Chain Polyunsaturated Fatty Acids and Adolescent Brain Development
NCT02590848 ·Status: COMPLETED ·Phase: NA
-
Omega-3 Supplementation for Pediatric Migraine
NCT06899074 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Effect of Long-Chain Polyunsaturated Fatty Acids on Cognitive Performance and Mood
NCT00615277 ·Status: COMPLETED ·Phase: NA
-
PUFA Supplementation in Premature Infants
NCT01955044 ·Status: COMPLETED ·Phase: NA
-
Investigations on Improving Docosahexaenoic and Arachidonic Acid Content in Preterm Infant Formula
NCT01300130 ·Status: COMPLETED ·Phase: NA
-
ω3 LCPUFAs for Healthy Growth and Development of Infants and Young Children in Southwest Ethiopia
NCT01817634 ·Status: COMPLETED ·Phase: NA
-
Essential Fatty Acids During Complementary Feeding
NCT00631046 ·Status: COMPLETED ·Phase: NA
-
Fatty Acids and Executive Function Development in 7-12 Year Olds
NCT02199808 ·Status: COMPLETED
-
Brain Responses to Short-Chain Fatty Acid Intervention
NCT06546683 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Cognitive Effects of 6- and 12-weeks Administration of a Food Supplement Containing Phosphatidylserine in Healthy Children Aged 8 to 12 Years
NCT05177978 ·Status: COMPLETED ·Phase: NA
-
Cognitive Effects of Omega-3 Supplements in Children With Mild to Moderate Malnutrition
NCT01199120 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Long Chain Polyunsaturated Fatty Acids on Behavior and Cognition in Children With Attention Deficit Hyperactivity Disorder
NCT01055119 ·Status: COMPLETED ·Phase: NA
-
Synergistic Activity of Human Milk Nutrients and Infant Cognition
NCT03838536 ·Status: RECRUITING ·Phase: NA
-
Activity of Essential Fatty Acid Elongation/Desaturation Pathway During Early Life in Human Infants, In Vivo
NCT00342303 ·Status: COMPLETED
-
Nutrigenomics, PUFA, Iron and Cognition Amongst Under-two-year-old Indonesian Children
NCT01504633 ·Status: UNKNOWN ·Phase: NA
-
Arachidonic Acid Supplementation in Very Preterm Infants
NCT02503020 ·Status: COMPLETED ·Phase: PHASE2
-
Bioavailability of Different Formulas Enriched With DHA Using Wet Mixing or Dry Blending Method
NCT04460287 ·Status: COMPLETED ·Phase: NA